Abstract
Women develop atrial fibrillation at an older age and have a higher risk of stroke than men. Female gender is an independent risk factor for not being in the therapeutic range of warfarin in the recently published SAMe-TT2R2 score. Even within the therapeutic range of warfarin, women remain at
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
